The latest health industry news to support important decisions

Reuters Health Industry Briefing offers health industry executives an effective way to keep abreast of the latest developments in the global health industry. Our coverage includes reporting of company, product and market news, regulatory affairs, drug pipelines, M&A activity, marketing and licensing agreements and drug safety issues.

Key features

  • Covers breaking healthcare sector business and commercial news across pharmaceutical, medical device and diagnostics, medical technology and biotech companies
  • Comprehensive international reporting from Reuters worldwide network of reporters
  • Flexible content, delivery and pricing options, including customized topic feeds
  • Access to daily updates and complete news archive
  • Approximately 25-30 stories per day

  • A valuable resource to support decision-making, management education and market and competitor
    analysis
  • Powerful support tool for account management and new business acquisition
  • Reliable and timely business intelligence information for corporate and hospital intranets
  • Constantly updated market information for corporate libraries
  • Availability: Global
  • Timing: Monday - Friday, including holidays
  • Delivery: Passive FTP, web browser, email
  • Formats: XML (IPTC NewsML), HTML and flat text formats
Industry
  • Genentech to make case for higher purchase price
  • Obama drug price plans spook Europe pharma investors
  • Beckman Coulter to buy Olympus diagnostics ops
  • Smith & Nephew orthopedic sales may slow in H2
  • Illumina to gain from higher U.S. research funding
  • Integra LifeSciences profit narrowly misses estimates
  • Intercell says Q4 pretax profit drops 71 pct
  • UCB seen hit by patent expiries in 2008l
Legal
  • U.S. ITC starts probe of glucosamine patent
  • Astellas files lawsuit against CV Therapeutics
Regulatory
  • Wyeth's Prevenar vaccine approved in Russia
  • U.S. regulators need more info on Actelion drug
Clinical
  • Acorda drug found to help MS patients walk better
  • Synta suspends skin-cancer trial on safety concerns
Drug & Device Development
  • Gene therapy edges towards commercial reality
Legislative
  • Stem cell research supporters offer U.S. Senate bill
Managed Care
  • Obama U.S. health budget raises hopes, worries
  • U.S. advisers urge broad Medicare payment reform

Contact Us

Editorial Planning Tools

Subscribe to Reuters daily news schedules at mediaexpress.reuters.com

Next Steps

Email